References
- Biswas J, Sharma T, Gopal L, et al. Eales disease–an update. Surv Ophthalmol. 2002;47(3):197–214. doi:10.1016/S0039-6257(02)00288-6.
- Biswas J, Ravi RK, Naryanasamy A, et al. Eales’ disease - current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3(1):11. doi:10.1186/1869-5760-3-11.
- Atmaca LS, Idil A, Gündüz K. Visualization of retinal vasculitis in Eales’ disease. Ocul Immunol Inflamm. 1993;1(1–2):41–48. doi:10.3109/09273949309086536.
- Das T, Biswas J, Kumar A, et al. Eales’ disease. Indian J Ophthalmol. 1994;42(1):3–18.
- Renie WA, Murphy RP, Anderson KC, et al. The evaluation of patients with Eales’ disease. Retina. 1983;3(4):243–248. doi:10.1097/00006982-198300340-00001.
- Finnoff WC. Some impressions derived from the study of recurrent hemorrhages into the retina and vitreous of young persons. Trans Am Ophthalmol Soc. 1921;19:238–258.
- Singh R, Toor P, Parchand S, et al. Quantitative polymerase chain reaction for Mycobacterium tuberculosis in so-called Eales’ disease. Ocul Immunol Inflamm. 2012;20(3):153–157. doi:10.3109/09273948.2012.658134.
- Donders PC. Eales’ disease. Doc Ophthalmol. 1958;12:1–105. doi:10.1007/BF00913469.
- Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol. 1993;38(3):229–256. doi:10.1016/0039-6257(93)90076-J.
- Madhavan HN, Therese KL, Gunisha P, et al. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales’ disease. Invest Ophthalmol Vis Sci. 2000;41(3):822–825.
- Im C, Kim Y. Spatial pattern of tuberculosis (TB) and related socio-environmental factors in South Korea, 2008-2016. PLoS One. 2021;16(8):e0255727. doi:10.1371/journal.pone.0255727.
- Go U, Park M, Kim UN, et al. Tuberculosis prevention and care in Korea: evolution of policy and practice. J Clin Tuberc Other Mycobact Dis. 2018;11:28–36. doi:10.1016/j.jctube.2018.04.006.
- Song KH, Jeon JH, Park WB, et al. Usefulness of the whole-blood interferon-gamma release assay for diagnosis of extrapulmonary tuberculosis. Diagn Microbiol Infect Dis. 2009;63(2):182–187. doi:10.1016/j.diagmicrobio.2008.10.013.
- Saxena S, Kumar D. A new staging system for idiopathic retinal periphlebitis. Eur J Ophthalmol. 2004;14(3):236–239. doi:10.1177/112067210401400308.
- Holladay JT. Proper method for calculating average visual acuity. J Refract Surg. 1997;13(4):388–391. doi:10.3928/1081-597X-19970701-16.
- Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30(2):287–290. doi:10.1016/j.jcrs.2004.01.014.
- Day AC, Donachie PH, Sparrow JM, et al. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye (Lond). 2015;29(4):552–560. doi:10.1038/eye.2015.3.
- Spitznas M, Meyer-Schwickerath G, Stephan B. The clinical picture of Eales’ disease. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1975;194(2):73–85. doi:10.1007/BF00413371.
- Biswas J, K.R R, Pal B, et al. Long-term outcomes of a large cohort of patients with Eales’ disease. Ocul Immunol Inflamm. 2018;26(6):870–876. doi:10.1080/09273948.2017.1298817.
- Oyakawa RT, Michels RG, Blase WP. Vitrectomy for nondiabetic vitreous hemorrhage. Am J Ophthalmol. 1983;96(4):517–525. doi:10.1016/S0002-9394(14)77916-4.
- Atmaca LS, Batioglu F, Atmaca Sonmez P. A long-term follow-up of Eales’ disease. Ocul Immunol Inflamm. 2002;10(3):213–221. doi:10.1076/ocii.10.3.213.15598.
- Gupta P, Biswas J. Further evidence of the association of latent Mycobacterium tuberculosis in Eales’ disease. Int Ophthalmol. Mar 2021;41(3):901–906. doi:10.1007/s10792-020-01645-5.
- Fountain JA, Werner RB. Tuberculous retinal vasculitis. Retina. 1984 Winter-Spring;4(1):48–50. doi:10.1097/00006982-198400410-00008.
- Hoh HB, Kong VY, Jaais F. Tuberculous retinal vasculitis. Med J Malaysia. September 1998;53(3):288–289.